Status:
COMPLETED
Green Coffee Extract Supplementation and Oxidative Stress, Systemic and Vascular Inflammation
Lead Sponsor:
National Nutrition and Food Technology Institute
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Metabolic syndrome (Mets) is defined as the collection of risk factors contributing to type 2 diabetes mellitus and cardiovascular disease. Mets is accompanied by oxidative stress and low-grade inflam...
Eligibility Criteria
Inclusion
- body mass index of over 25, waist circumference \>102 cm in men or \>88 cm in women,Fasting blood glucose \>100 mg/dL, Triglycerides (TG) \> 150 mg/dL, High density lipoprotein cholesterol (HDL-C) \<50 in women or \<40 in men, Systolic blood pressure (SBP) \>130 mmHg and diastolic blood pressure (DBP) \>85mmHg
Exclusion
- insulin administration for diabetes control, having hypo- or hyperthyroidism, renal failure or other chronic diseases, regular coffee consumption, pregnancy, breastfeeding, taking estrogen, progesterone, corticosteroids, weight loss supplements and obeying unusual weight loss plans
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 18 2017
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03265184
Start Date
January 1 2017
End Date
July 18 2017
Last Update
August 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.